ARTICLES BY MATHINI ILANCHERAN
-
U.S. Pharma Tariffs And MFN Become Law After April 2 Update4/15/2026
Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing10/17/2025
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.